COO
COOPER COMPANIES, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$64.69
+6.35%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$62.44
From 52W high−23.28%
Volume1.47M
Market cap$12.30B
P/E (TTM)22.1x
P/S (TTM)2.9x
Div yield—
Key dataNov 4, 2026
Open
$62.44
From 52W high
−23.28%
Volume
1.47M
Market cap
$12.30B
ValuationView details →
P/E (Fwd)
13.9x
EV/EBITDA
16.1x
P/E (TTM)
22.1x
RSI (14)
66.4
MomentumView details →
1D Return
+6.35%
YTD Return
−21.68%
SummaryUpdated Jul 1, 2026
The Cooper Companies, Inc. (NYSE:COO) is a global medical device company founded in 1958 and headquartered in San Ramon, California. The company has evolved from its origins into a leading manufacturer of contact lenses and women's healthcare products. Cooper Companies went public in 1983 and has grown through strategic acquisitions and organic expansion to become a significant player in the medical devices industry, operating in over 100 countries worldwide with annual revenues approaching $4 billion.
Similar companies
Latest newsMore news →
Albert G. White III resigned as President and Chief Executive Officer of Cooper Companies, effective October 27, 2026.7d agoCOOPER COMPANIES, INC. elected independent director Walt Rosebrough as executive chair and said a search for a CEO is underway.8d agoJana Partners, a New York hedge fund, has been an investor in Fiserv since late 2025 and is pressing the payments company to double its cost-cut target and adopt Palantir products.37d ago